University Of Rhode Island Board Of Trustees

University Of Rhode Island Board Of Trustees has been granted 32 US utility patents between 2020 and 2025, placing University Of Rhode Island Board Of Trustees at rank #9,915 across all assignees tracked by PlainPatent. This portfolio spans 38 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.2 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, University Of Rhode Island Board Of Trustees is one of the more focused assignees in the PatentsView dataset. By volume, University sits between University OF South Australia (32 patents, rank #9,911) and Vesper Medical, Inc. (32 patents, rank #9,919) - the closest US assignees by grant volume. The composite Innovation Score of 66.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 32 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. University Of Rhode Island Board Of Trustees's 21.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 38 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark University Of Rhode Island Board Of Trustees against peers pursuing similar technology classes.